Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TERT | O14746 | 7/20 | 0.79 |
| ▸ | MAPT | P10636 | 5/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.56 |
| ▸ | MEN1 | O00255 | 2/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | POLB | P06746 | 2/20 | 0.56 |
| ▸ | RAD52 | P43351 | 2/20 | 0.56 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.56 |
| ▸ | EGFR | P00533 | 2/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | HTT | P42858 | 1/20 | 0.56 |
| ▸ | RECQL | P46063 | 1/20 | 0.56 |
| ▸ | BLM | P54132 | 1/20 | 0.56 |
| ▸ | GAA | P10253 | 1/20 | 0.55 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.55 |
| ▸ | SMARCA2 | P51531 | 1/20 | 0.55 |
| ▸ | NSD2 | O96028 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5605466 | 0.95 | TERT (0.72) | TERTMAPTKMT2AMAPK1MEN1 | |
| SCHEMBL9364080 | 0.94 | TERT (0.71) | TERTMAPTKMT2AMAPK1MEN1 | |
| SCHEMBL31218598 | 0.94 | TERT (0.71) | TERTMAPTKMT2AMAPK1MEN1 | |
| SCHEMBL5605310 | 0.91 | TERT (0.79) | TERTMAPTKMT2AMAPK1MEN1 | |
| SCHEMBL6364970 | 0.91 | TERT (0.67) | TERTMAPTKMT2AMAPK1MEN1 | |
| SCHEMBL10046651 | 0.89 | TERT (0.65) | TERTMAPTKMT2AMAPK1MEN1 | |
| SCHEMBL11688579 | 0.87 | TERT (0.73) | TERTMAPTKMT2AMAPK1MEN1 | |
| Hydrochloric Acid SCHEMBL11691265 | 0.85 | TERT (0.71) | TERTMAPTKMT2AMAPK1MEN1 | |
| SCHEMBL3416154 | 0.84 | TERT (0.62) | TERTMAPTKMT2AMAPK1MEN1 | |
| SCHEMBL7152625 | 0.83 | TERT (0.57) | TERTMAPTKMT2AMAPK1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7202292-B2 | Colored polymeric resin composition with 1,8-diaminoanthraquinone derivative, article made therefrom, and method for making the same | GENERAL ELECTRIC COMPANY (US) | 2007-04-10 | — | — | US | claimed |
| US-7691418-B2 | Composition for inhibiting or preventing the formation of a biofilm | OYSTERSHELL NV (BE) | 2010-04-06 | — | — | US | disclosed |
| US-20070258913-A1 | Composition for Inhibiting or Preventing the Formation of a Biofilm | OYSTERSHELL NV (BE) | 2007-11-08 | — | — | US | disclosed |
| US-7202292-B2 | Colored polymeric resin composition with 1,8-diaminoanthraquinone derivative, article made therefrom, and method for making the same | GENERAL ELECTRIC COMPANY (US) | 2007-04-10 | — | — | US | disclosed |
| US-7087282-B2 | Limited play optical storage medium, method for making the same | GENERAL ELECTRIC COMPANY (US) | 2006-08-08 | — | — | US | disclosed |
| EP-1647011-A1 | LIMITED PLAY OPTICAL STORAGE MEDIUM, METHOD FOR MAKING THE SAME | GENERAL ELECTRIC COMPANY (US) | 2006-04-19 | — | — | EP | disclosed |
| EP-1646682-A1 | COLORED POLYMERIC RESIN COMPOSITION, ARTICLE MADE THEREFROM, AND METHOD FOR MAKING THE SAME | GENERAL ELECTRIC COMPANY (US) | 2006-04-19 | — | — | EP | disclosed |
| WO-2005010090-A1 | COLORED POLYMERIC RESIN COMPOSITION, ARTICLE MADE THEREFROM, AND METHOD FOR MAKING THE SAME | GENERAL ELECTRIC COMPANY (US) | 2005-02-03 | — | — | WO | disclosed |
| WO-2005010872-A1 | LIMITED PLAY OPTICAL STORAGE MEDIUM, METHOD FOR MAKING THE SAME | GENERAL ELECTRIC COMPANY (US) | 2005-02-03 | — | — | WO | disclosed |
| US-20050014878-A1 | Colored polymeric resin composition, article made therefrom, and method for making the same | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2005-01-20 | — | — | US | disclosed |
| US-20050013232-A1 | Limited play optical storage medium, method for making the same | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2005-01-20 | — | — | US | disclosed |
| EP-0450021-B1 | ANTI-CANCER COMPOUNDS | BRITISH TECH GROUP (GB) | 1994-02-02 | — | — | EP | disclosed |
| US-5132327-A | ANTI-CANCER COMPOUNDS | NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) | 1992-07-21 | — | — | US | disclosed |
| WO-1991005824-A1 | ANTI-CANCER COMPOUNDS | NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) | 1991-05-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070258913-A1 | Composition for Inhibiting or Preventing the Formation of a Biofilm | NQO2, NFKBIA, CROCC | TERT 851/4885MAPT 4695/4885KMT2A 3594/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.